Paper7948302
P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.
Licht T and 3 others. Ann Hematol, 1994. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Papers, record 7948302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7948302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Drug Resistance, Multiple | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Leukemia | Major topic |
| Humans | |
| Lymphoma | |
| Multiple Myeloma |
Source PubMed
References168
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2563168 | Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2563168 | PubMed |
| 2 | 7693039 | Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. | Blood | 1993 | https://conductscience.org/library/papers/7693039 | PubMed |
| 3 | 1974821 | Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. | Cancer | 1990 | https://conductscience.org/library/papers/1974821 | PubMed |
| 4 | 2481487 | Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2481487 | PubMed |
| 5 | 1352414 | Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. | Science | 1992 | https://conductscience.org/library/papers/1352414 | PubMed |
| 6 | 1687990 | Expression of the multidrug transporter P-glycoprotein and in vitro chemosensitivity: correlation with in vivo response to chemotherapy in acute myeloid leukemia. | Sel Cancer Ther | 1991 | https://conductscience.org/library/papers/1687990 | PubMed |
| 7 | 8104940 | Fluorescent cellular indicators are extruded by the multidrug resistance protein. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8104940 | PubMed |
| 8 | 1680550 | Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. | Cancer Res | 1991 | https://conductscience.org/library/papers/1680550 | PubMed |
| 9 | 2406450 | Tumor hypoxia, drug resistance, and metastases. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2406450 | PubMed |
| 10 | 1360821 | PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia. | Ann Hematol | 1992 | https://conductscience.org/library/papers/1360821 | PubMed |
| 11 | 7901453 | Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance. | Leuk Res | 1993 | https://conductscience.org/library/papers/7901453 | PubMed |
| 12 | 1352877 | Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1352877 | PubMed |
| 13 | 8095909 | Cleavage of human MDR1 mRNA by a hammerhead ribozyme. | FEBS Lett | 1993 | https://conductscience.org/library/papers/8095909 | PubMed |
| 14 | 3768958 | Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. | Cell | 1986 | https://conductscience.org/library/papers/3768958 | PubMed |
| 15 | 8252468 | Clinical trials of agents that reverse multidrug resistance. A literature review. | Cancer | 1993 | https://conductscience.org/library/papers/8252468 | PubMed |
| 16 | 8093668 | P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. | Blood | 1993 | https://conductscience.org/library/papers/8093668 | PubMed |
| 17 | 2432605 | Expression of a multidrug-resistance gene in human tumors and tissues. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2432605 | PubMed |
| 18 | 1380280 | Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1380280 | PubMed |
| 19 | 1672384 | Magnetic-affinity cell sorting of human multidrug-resistant cells. | J Natl Cancer Inst | 1991 | https://conductscience.org/library/papers/1672384 | PubMed |
| 20 | 1911388 | Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL). | Br J Haematol | 1991 | https://conductscience.org/library/papers/1911388 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42736272 | Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42736272 | PubMed |
| 31624330 | Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells. | Sci Rep | 2019 | https://conductscience.org/library/papers/31624330 | PubMed |
| 29507678 | Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. | Oncotarget | 2018 | https://conductscience.org/library/papers/29507678 | PubMed |
| 27650066 | Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells. | Mol Genet Metab | 2016 | https://conductscience.org/library/papers/27650066 | PubMed |
| 23011844 | Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study. | Clin Orthop Relat Res | 2013 | https://conductscience.org/library/papers/23011844 | PubMed |
| 20520719 | Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. | PLoS One | 2010 | https://conductscience.org/library/papers/20520719 | PubMed |
| 20505985 | Nanoparticles: a promising modality in the treatment of sarcomas. | Pharm Res | 2011 | https://conductscience.org/library/papers/20505985 | PubMed |
| 19499189 | Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. | Invest New Drugs | 2010 | https://conductscience.org/library/papers/19499189 | PubMed |
| 15681895 | Immunosuppressive interactions among calcium channel antagonists and selected corticosteroids and macrolides using human whole blood lymphocytes. | Drug Metab Pharmacokinet | 2004 | https://conductscience.org/library/papers/15681895 | PubMed |
| 15316104 | Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15316104 | PubMed |
| 11368437 | Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia. | Leukemia | 2001 | https://conductscience.org/library/papers/11368437 | PubMed |
| 10552331 | Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival. | Surg Today | 1999 | https://conductscience.org/library/papers/10552331 | PubMed |
| 10515904 | Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. | Clin Microbiol Rev | 1999 | https://conductscience.org/library/papers/10515904 | PubMed |
| 9232613 | Classical multidrug resistance in acute myeloid leukaemia. | Med Oncol | 1997 | https://conductscience.org/library/papers/9232613 | PubMed |
| 8956784 | Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8956784 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7948302
GET https://conductscience.org/api/papers/v1/7948302/references?page=2